racemetirosine has been researched along with Abnormality, Heart in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, RH | 1 |
| Kolesari, GL | 1 |
| Kalbfleisch, JH | 1 |
1 other study available for racemetirosine and Abnormality, Heart
| Article | Year |
|---|---|
Pharmacology of dextroamphetamine-induced cardiovascular malformations in the chick embryo.
Topics: Abnormalities, Drug-Induced; alpha-Methyltyrosine; Animals; Chick Embryo; Dextroamphetamine; Heart D | 1983 |